Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Patient Safety

Content :

Social responsibility
PATIENT SAFETY

Counterfeit drugs are designed to deceive consumers by using misleading packaging and mimicking the shape, color, size, and imprints of genuine drugs. Often, counterfeit drugs contain trace amounts of the alleged active ingredients and sometimes have no active ingredients at all.


Sanofi is committed to eradicating these illegal operations. Why? Because taking counterfeit medications can cost patients their lives. As a company, we are involved with many organizations, including international pharmaceutical associations, and law enforcement agencies to address this ever-growing problem.

In January 2011, Sanofi implemented a two-dimensional (2D) barcoding identification system, called Data Matrix, a French legislative requirement. Additionally, Sanofi went a step further using the identification system for at-risk products on an international level. In December 2011, Sanofi Pasteur US shipped its first 2D barcoded units of Pediatric Diphtheria and Tetanus Toxoid Adsorbed (DT) vaccine – becoming the first manufacturer in the vaccine industry to implement this innovative technology on the unit-of-use.

Vaccine vial with 2-D barcode
Vaccine vial with 2-D barcode

The system consists of a two-dimensional barcode printer on each box that contains tracking information: product code (CIP code), batch number and expiration date. Data Matrix codes are read when drugs are dispensed, improving traceability and enabling automatic detection of falsified or expired products. They also facilitate batch recalls.

Another facet of this Data Matrix identification system is that it provides disabled patients, including blind patients and those with a visual or mental impairment, with the tools to understand what product they are purchasing. The Notiris software can read the information contained in the Data Matrix code by connecting to a specific database that provides the drug's name, dosage and expiration date. The information is given orally and in writing. The product leaflet is now accessible thanks to the software, which has been available to PC, Mac and smartphone users since 2012.

To read more about Sanofi’s global efforts to combat counterfeit drugs, click here.

The fight against conterfeit drugsPatient Information

US.COR.17.02.011


Last update: March 22, 2017